Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Huquan Pharmaceutical is a comprehensive pharmaceutical enterprise based in Wuhan, China, specializing in the research, development, and manufacturing of chemical drugs and Traditional Chinese Medicine (TCM). The company operates modern, GMP-certified production facilities capable of producing various dosage forms, including tablets, capsules, and granules. Its product portfolio is primarily focused on the domestic Chinese market, with a strong emphasis on respiratory health, anti-infectives, and over-the-counter (OTC) medications. Huquan is well-known for its treatments for the common cold and influenza, maintaining a significant presence in regional distribution networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Huquan Pharmaceutical.